Defense counsel in the Zoloft multidistrict litigation argued in federal court Wednesday that scientific and medical issues should take primacy in pretrial proceedings because as one lawyer said, “there’s just no science there.”

But plaintiffs counsel argued that discovery can proceed on multi-tracks for both Pfizer’s alleged liability and for the science behind the allegations that women’s use of the popular antidepressant during their pregnancies caused birth defects in their children.